| | Item | Percentage of strongly agree | Percentage of agree | Percentage of neither agree nor disagree | Percentage of disagree | Percentage of strongly disagree |
| | The results of antiangiogenic therapy could differ from the results of clinical trials because these protocols are frequently difficult to use in real clinical practice. | 62,5 | 37,5 | 0 | 0 | 0 |
| | Ideally, a personalized retreatment that keeps in mind the risks and benefits and avoids the over- and undertreatment of the patient should be done. | 75 | 25 | 0 | 0 | 0 |
| | Generally it is advisable to begin the treatment with a loading phase of three injections. | 87,5 | 12,5 | 0 | 0 | 0 |
| | In order to reduce assistance burden, complementary examinations could be avoided during the loading phase or be reduced to a minimum exploring only VA and OCT. | 56,25 | 31,25 | 12,5 | 0 | 0 |
| | In some monitoring visits in which the treatment has been previously decided, the examinations could be omitted. | 43,75 | 37,5 | 12,5 | 0 | 6,25 |
| | It would be advisable that examinations such as VA and OCT would be performed by technical staff, while the ophthalmologist interprets the results and makes treatment decisions | 50 | 43,75 | 6,25 | 0 | 0 |
| | In case of following the PRN regimen, reinjection is recommended in the case of evidence of disease activity in the OCT, new hemorrhage or vision loss due to the disease activity. | 62,5 | 37,5 | 0 | 0 | 0 |
| | The T&E regimen could be a useful protocol to reduce the number of revisions and the burden of the disease. | 37,5 | 56,25 | 0 | 6,25 | 0 |
| | In the presence of a relapse it is recommended to continue with the treatment until the retreatment criteria disappears. | 43,25 | 50 | 6,25 | 0 | 0 |
| | When retreating due to a relapse, if it is not possible to follow established monitoring guidelines, a new loading phase may be considered without performing the associated examinations | 37,5 | 56,25 | 6,25 | 0 | 0 |
| | Ideally, the relapses should be treated the same day they are diagnosed. | 62,25 | 25 | 12,5 | 0 | 0 |
| | It is as adequate and safe to perform intravitreal injections in a clean room as in an operating room. | 56,25 | 31,25 | 12,5 | 0 | 0 |
| | “Absolute” nonresponders are defined as those who after the three loading doses still have worsening VA and OCT | 68,75 | 31,25 | 0 | 0 | 0 |
| | In nonresponders, the guidelines have to be decided after doing an ICG (to rule out diseases as CP or RAP) | 62,5 | 31,25 | 6,25 | 0 | 0 |
| | It would be recommendable to refer patients to a general ophthalmologist who have not presented with retreatment criteria in the last 12 months or who have the disease in a disciform state. | 50 | 31,25 | 12,5 | 6,25 | 0 |
|
|
